Loading
Latest filing published 12 Aug 2016 for China Biologic Products, Inc..
No signal scores available.
David Hui Li appears in our data through filings on China Biologic Products, Inc. shares, published by SEC (Form 4). The record holds 5 filings, for trades running from 22 February 2016 to 11 August 2016.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 12 August 2016 came the latest disclosure, a share grant in China Biologic Products, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 7 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations